Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2016

  • ID: 3960448
  • Company Profile
  • 72 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Chrysalis Pharma SAS
  • Griffin Discoveries BV
  • Johnson & Johnson
  • OSE Immunotherapeutics
  • Palau Pharma, S.A.
  • Sensorion S.A.
  • MORE
Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2016

The report ‘Lee's Pharmaceutical Holdings Limited - Product Pipeline Review - 2016’, provides an overview of the Lee's Pharmaceutical Holdings Limited’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Lee's Pharmaceutical Holdings Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Lee's Pharmaceutical Holdings Limited
- The report provides overview of Lee's Pharmaceutical Holdings Limited including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Lee's Pharmaceutical Holdings Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Lee's Pharmaceutical Holdings Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Lee's Pharmaceutical Holdings Limited’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Lee's Pharmaceutical Holdings Limited
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Lee's Pharmaceutical Holdings Limited’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Chrysalis Pharma SAS
  • Griffin Discoveries BV
  • Johnson & Johnson
  • OSE Immunotherapeutics
  • Palau Pharma, S.A.
  • Sensorion S.A.
  • MORE
Introduction

Lee's Pharmaceutical Holdings Limited Snapshot

Lee's Pharmaceutical Holdings Limited Overview

Key Facts

Lee's Pharmaceutical Holdings Limited - Research and Development Overview

Key Therapeutic Areas

Lee's Pharmaceutical Holdings Limited - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Lee's Pharmaceutical Holdings Limited - Pipeline Products Glance

Lee's Pharmaceutical Holdings Limited - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Lee's Pharmaceutical Holdings Limited - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Lee's Pharmaceutical Holdings Limited - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Lee's Pharmaceutical Holdings Limited - Drug Profiles

(adapalene + clindamycin hydrochloride) - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AK-12 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

azilsartan - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

gimatecan - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

istaroxime - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

levobetaxolol hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

levocarnitine propionate hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

LQ-7 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

pazufloxacin - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

procarbazine hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

RGN-259 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rostafuroxin - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

STIA-1014 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

tecarfarin sodium - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

trazodone hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-001 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-002 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-003 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-004 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-009 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-010 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-011 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-012 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-013 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-014 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-015 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ZK-016 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Lee's Pharmaceutical Holdings Limited - Pipeline Analysis

Lee's Pharmaceutical Holdings Limited - Pipeline Products by Target

Lee's Pharmaceutical Holdings Limited - Pipeline Products by Route of Administration

Lee's Pharmaceutical Holdings Limited - Pipeline Products by Molecule Type

Lee's Pharmaceutical Holdings Limited - Pipeline Products by Mechanism of Action

Lee's Pharmaceutical Holdings Limited - Dormant Projects

Lee's Pharmaceutical Holdings Limited - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

betrixaban

ecallantide

gimatecan

NOV-002

NOV-205

prulifloxacin

RGN-259

Lee's Pharmaceutical Holdings Limited - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

Lee's Pharmaceutical Holdings Limited, Key Facts

Lee's Pharmaceutical Holdings Limited - Pipeline by Indication, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Stage of Development, 2016

Lee's Pharmaceutical Holdings Limited - Monotherapy Products in Pipeline, 2016

Lee's Pharmaceutical Holdings Limited - Combination Treatment Modalities in Pipeline, 2016

Lee's Pharmaceutical Holdings Limited - Partnered Products in Pipeline, 2016

Lee's Pharmaceutical Holdings Limited - Partnered Products/ Combination Treatment Modalities, 2016

Lee's Pharmaceutical Holdings Limited - Pre-Registration, 2016

Lee's Pharmaceutical Holdings Limited - Phase III, 2016

Lee's Pharmaceutical Holdings Limited - Phase II, 2016

Lee's Pharmaceutical Holdings Limited - Phase I, 2016

Lee's Pharmaceutical Holdings Limited - IND/CTA Filed, 2016

Lee's Pharmaceutical Holdings Limited - Preclinical, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Target, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Route of Administration, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Molecule Type, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline Products by Mechanism of Action, 2016

Lee's Pharmaceutical Holdings Limited - Dormant Developmental Projects,2016

Lee's Pharmaceutical Holdings Limited - Discontinued Pipeline Products, 2016

Lee's Pharmaceutical Holdings Limited, Subsidiaries

List of Figures

Lee's Pharmaceutical Holdings Limited - Pipeline by Top 10 Indication, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Stage of Development, 2016

Lee's Pharmaceutical Holdings Limited - Monotherapy Products in Pipeline, 2016

Lee's Pharmaceutical Holdings Limited - Partnered Products in Pipeline, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Top 10 Target, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Route of Administration, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline by Molecule Type, 2016

Lee's Pharmaceutical Holdings Limited - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Chrysalis Pharma SAS
- Griffin Discoveries BV
- Johnson & Johnson
- OSE Immunotherapeutics
- Palau Pharma, S.A.
- Sensorion S.A.
- Ziarco Pharma Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll